Privately-held Imvax, a biotech developing personalized, whole tumor-derived immunotherapies, has announced top line results ...

Among nearly 3,000 patients, those treated with PA-PPIs such as omeprazole (Prilosec) or pantoprazole (Protonix) had worse ...

In this retrospective analysis, researchers aimed to evaluate outcomes of continuing next-generation ALK TKIs plus chemotherapy after progression on TKI monotherapy in patients with ALK-positive NSCLC ...

In October 2025, Samsung Bioepis announced that the company will assume full commercial responsibility for BYOOVIZ in Europe upon full transition of Biogen’s commercialization rights back to Samsung ...

Striver is a specialist wealth management career and talent development platform designed to connect employers with ...

While limited data suggest loncastuximab tesirine plus rituximab may be active in the third line, larger cohorts and ...

Entireti has partnered with specialist wealth management and talent development platform Striver to launch a program that supports the next generation of financial advisers.

Overall survival was twice as long for people treated with Columvi in combination with GemOx versus MabThera/Rituxan plus GemOx1This Columvi combination is available off-the-shelf and could offer a ...

VEN+O is a cost-effective treatment for untreated, fit CLL patients, offering superior progression-free survival and cost savings compared to most alternatives. The study used a cost-utility analysis, ...

VANCOUVER, BC, Nov. 24, 2025 /CNW/ - Defense Metals Corp. ("Defense Metals" or the "Company") (TSXV: DEFN) (OTCQB: DFMTF) (FSE: 35D), a company ...

ISELIN, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, and The Provident Bank Foundation (PBF) have partnered to launch a Crisis Response ...

Planning for the 2026 field campaign is under way with up to 5,000m of diamond drilling proposed, designed as a series of ...